82_FR_10050 82 FR 10024 - National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting

82 FR 10024 - National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 82, Issue 26 (February 9, 2017)

Page Range10024-10025
FR Document2017-02727

Federal Register, Volume 82 Issue 26 (Thursday, February 9, 2017) 
[Federal Register Volume 82, Number 26 (Thursday, February 9, 2017)]
[Notices]
[Pages 10024-10025]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2017-02727]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel NIAID, Clinical Trial Planning Grant 
(R34) and Implementation Cooperative Agreement (U01).
    Date: March 6, 2017.
    Time: 10:00 a.m. to 12:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 5601 Fishers Lane, 
Rockville, MD 20892 (Telephone Conference Call).
    Contact Person: Maryam Feili-Hariri, Ph.D., Scientific Review 
Officer, Scientific Review Program, Division of Extramural 
Activities, National Institutes of Health/NIAID, 5601 Fishers Lane, 
Rockville, MD 20852, 240-669-5026, [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)


[[Page 10025]]


    Dated: February 6, 2017.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-02727 Filed 2-8-17; 8:45 am]
BILLING CODE 4140-01-P

10024 Federal Register / Vol. 82, No. 26 / Thursday, February 9, 2017 / Notices DEPARTMENT OF HEALTH AND the discussions could disclose Place: Hilton Garden Inn Bethesda, 7301 HUMAN SERVICES confidential trade secrets or commercial Waverly Street, Bethesda, MD 20814. property such as patentable material, Contact Person: Brian Hoshaw, Ph.D., National Institutes of Health and personal information concerning Scientific Review Officer, National Eye individuals associated with the prize Institute, National Institutes of Health, National Institute on Minority Health Division of Extramural Research, 5635 submissions, the disclosure of which and Health Disparities; Notice of Fishers Lane, Suite 1300, Rockville, MD would constitute a clearly unwarranted 20892, Closed Meeting invasion of personal privacy. 301–451–2020, hoshawb@mail.nih.gov. Pursuant to section 10(d) of the Name of Committee: Center for Scientific (Catalogue of Federal Domestic Assistance Federal Advisory Committee Act, as Review Special Emphasis Panel; OD16–137: Program Nos. 93.867, Vision Research, amended (5 U.S.C. App.), notice is Antimicrobial Resistance Rapid, Point-of- National Institutes of Health, HHS) hereby given of the following meeting. Need Diagnostic Test Challenge: Step 1. Date: March 2–3, 2017. Dated: February 3, 2017. The meeting will be closed to the Time: 8:00 a.m. to 5:30 p.m. Natasha M. Copeland, public in accordance with the Agenda: To review and evaluate prize provisions set forth in sections Program Analyst, Office of Federal Advisory submissions. Committee Policy. 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Place: Residence Inn Bethesda, 7335 [FR Doc. 2017–02617 Filed 2–8–17; 8:45 am] as amended. The grant applications and Wisconsin Avenue, Bethesda, MD 20814. the discussions could disclose Contact Person: Gagan Pandya, Ph.D., BILLING CODE 4140–01–P confidential trade secrets or commercial Scientific Review Officer, National Institutes property such as patentable materials, of Health, Center for Scientific Review, 6701 and personal information concerning Rockledge Drive, Rm. 3200, MSC 7808, DEPARTMENT OF HEALTH AND Bethesda, MD 20892, 301–435–1167, HUMAN SERVICES individuals associated with the grant pandyaga@mail.nih.gov. applications, the disclosure of which National Institutes of Health (Catalogue of Federal Domestic Assistance would constitute a clearly unwarranted Program Nos. 93.306, Comparative Medicine; invasion of personal privacy. 93.333, Clinical Research, 93.306, 93.333, National Institute of Allergy and Name of Committee: National Institute on 93.337, 93.393–93.396, 93.837–93.844, Infectious Diseases; Notice of Closed Minority Health and Health Disparities 93.846–93.878, 93.892, 93.893, National Meeting Special Emphasis Panel; ZMD1 DRI (M1) NIH Institutes of Health, HHS) Support for Conference and Scientific Dated: February 3, 2017. Pursuant to section 10(d) of the Meetings (Parent R13). Federal Advisory Committee Act, as Anna Snouffer, Date: March 3, 2017. amended (5 U.S.C. App.), notice is Time: 12:00 p.m. to 5:00 p.m. Deputy Director, Office of Federal Advisory Agenda: To review and evaluate grant Committee Policy. hereby given of the following meeting. applications. [FR Doc. 2017–02619 Filed 2–8–17; 8:45 am] The meeting will be closed to the Place: National Institutes of Health, Two BILLING CODE 4140–01–P public in accordance with the Democracy Plaza, 6701 Democracy provisions set forth in sections Boulevard, Bethesda, MD 20852. 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Contact Person: Deborah Ismond, Ph.D., DEPARTMENT OF HEALTH AND as amended. The grant applications and Scientific Review Officer, Division of HUMAN SERVICES Scientific Programs, National Institute on the discussions could disclose Minority Health and Health Disparities, confidential trade secrets or commercial National Institutes of Health property such as patentable material, National Institutes of Health, 6707 Democracy Blvd., Suite 800, Bethesda, MD National Eye Institute; Notice of Closed and personal information concerning 20892, (301) 402–1366, ismonddr@ Meeting individuals associated with the grant mail.nih.gov. applications, the disclosure of which Dated: February 2, 2017. Pursuant to section 10(d) of the would constitute a clearly unwarranted David Clary, Federal Advisory Committee Act, as invasion of personal privacy. amended (5 U.S.C. App.), notice is Name of Committee: National Institute of Program Analyst, Office of Federal Advisory Committee Policy. hereby given of the following meeting. Allergy and Infectious Diseases Special The meeting will be closed to the Emphasis Panel NIAID, Clinical Trial [FR Doc. 2017–02616 Filed 2–8–17; 8:45 am] public in accordance with the Planning Grant (R34) and Implementation BILLING CODE 4140–01–P Cooperative Agreement (U01). provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Date: March 6, 2017. as amended. The grant applications and Time: 10:00 a.m. to 12:00 p.m. DEPARTMENT OF HEALTH AND Agenda: To review and evaluate grant the discussions could disclose HUMAN SERVICES applications. confidential trade secrets or commercial Place: National Institutes of Health, 5601 National Institutes of Health property such as patentable material, Fishers Lane, Rockville, MD 20892 and personal information concerning (Telephone Conference Call). Center for Scientific Review; Notice of individuals associated with the grant Contact Person: Maryam Feili-Hariri, Closed Meeting applications, the disclosure of which Ph.D., Scientific Review Officer, Scientific would constitute a clearly unwarranted Review Program, Division of Extramural Pursuant to section 10(d) of the invasion of personal privacy. Activities, National Institutes of Health/ sradovich on DSK3GMQ082PROD with NOTICES Federal Advisory Committee Act, as NIAID, 5601 Fishers Lane, Rockville, MD amended (5 U.S.C. App.), notice is Name of Committee: National Eye Institute Special Emphasis Panel; NEI Center Core 20852, 240–669–5026, haririmf@ hereby given of the following meeting. niaid.nih.gov. Grants (P30) and Pathways to Independence The meeting will be closed to the Awards (K99). (Catalogue of Federal Domestic Assistance public in accordance with the Date: March 6, 2017. Program Nos. 93.855, Allergy, Immunology, provisions set forth in sections Time: 8:00 a.m. to 5:00 p.m. and Transplantation Research; 93.856, 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Agenda: To review and evaluate grant Microbiology and Infectious Diseases as amended. The prize submissions and applications. Research, National Institutes of Health, HHS) VerDate Sep<11>2014 18:11 Feb 08, 2017 Jkt 241001 PO 00000 Frm 00042 Fmt 4703 Sfmt 4703 E:\FR\FM\09FEN1.SGM 09FEN1

Federal Register / Vol. 82, No. 26 / Thursday, February 9, 2017 / Notices 10025 Dated: February 6, 2017. foreign patent applications claiming Commercialization Patent License Natasha M. Copeland, priority to the aforementioned Agreement. Comments and objections Program Analyst, Office of Federal Advisory applications. submitted to this notice will not be Committee Policy. United States Provisional Patent made available for public inspection [FR Doc. 2017–02727 Filed 2–8–17; 8:45 am] Application No. 61/474,583, filed April and, to the extent permitted by law, will BILLING CODE 4140–01–P 12, 2011 and entitled ‘‘Plasmodial not be released under the Freedom of Surface Anion Channel Inhibitors for Information Act, 5 U.S.C. 552. the Treatment of Malaria’’ [HHS Dated: February 6, 2017. DEPARTMENT OF HEALTH AND Reference No. E–145–2011/0–US–01]; Suzanne Frisbie, HUMAN SERVICES PCT Patent Application PCT/US12/ 33072, filed April 11, 2012 and entitled Deputy Director, Technology Transfer and National Institutes of Health Intellectual Property Office, National Institute ‘‘Plasmodial Surface Anion Channel of Allergy and Infectious Diseases. Inhibitors for the Treatment of Malaria’’ Prospective Grant of Exclusive Patent [FR Doc. 2017–02673 Filed 2–8–17; 8:45 am] [HHS Reference No. E–202–2008/0– License: Inhibition of Plasmodial PCT–02]; and U.S. and foreign patent BILLING CODE 4140–01–P Surface Anion Channels for the applications claiming priority to the Treatment or Prevention of Malaria aforementioned applications. The patent rights in these inventions DEPARTMENT OF THE INTERIOR AGENCY: National Institutes of Health, HHS. have been assigned to the government of the United States of America. Geological Survey ACTION: Notice. The prospective exclusive license [17 GX17CJ00GKC0100] SUMMARY: The National Institute of territory may be worldwide and the Allergy and Infectious Diseases, an field of use may be limited to: ‘‘Methods Notice of an Open Meeting of the institute of the National Institutes of of preventing and/or treating malaria Advisory Committee on Water Health, Department of Health and infection by inhibition of Plasmodium Information Human Services, is contemplating the Surface Anion Channels (PSAC) with anti-PSAC compounds.’’ AGENCY: United States Geological grant of an Exclusive Commercialization Survey, Department of the Interior. Patent License to practice the inventions This technology discloses a novel embodied in the Patents and Patent anion channel on the surface of red ACTION: Notice of an open meeting of the Applications listed in the Summary blood cells (RBCs) in animals infected Advisory Committee on Water Information section of this notice to with Plasmodium. Named PSAC for Information (ACWI). Microbiotix, Inc. (‘‘Microbiotix’’) ‘‘plasmodium surface anion channel,’’ this channel protein facilitates the SUMMARY: Notice is hereby given of a located in Worcester, Massachusetts. meeting of the ACWI. This meeting is to transport of nutrients into RBCs for the DATES: Only written comments and/or discuss broad policy-related topics plasmodium parasite. Sugars, amino applications for a license which are acids, purines, vitamins, and precursors relating to national water initiatives, received by the National Institute of for phospholipid biosynthesis have and the development and dissemination Allergy and Infectious Diseases’ markedly increased uptake into infected of water information, through reports Technology Transfer and Intellectual RBCs via PSAC. Many of these nutrients from ACWI subgroups. The agenda will Property Office on or before February have negligible uptake in uninfected include updates from ACWI’s various 24, 2017 will be considered. RBCs. PSACs, which allow nutrients to subcommittees, unveiling of the ADDRESSES: Requests for copies of the reach the growing plasmodium parasites strategic plan for the Water Quality patent application, inquiries, and inside RBCs, therefore serves as a new Portal for 2017–2021, a proposal for a comments relating to the contemplated target for the development of new Terms of Reference document for Exclusive Commercialization Patent antimalarial compounds. The disclosed the Subcommittee on Ground Water, a License should be directed to: Peter anti-PSAC compositions and methods of proposal to establish a new Risk Tung, Technology Transfer and Patent using these anti-PSAC compounds Management Workgroup within the Specialist, Technology Transfer and provide a means for prevention or Subcommittee on Hydrology, an update Intellectual Property Office, National treatment of malaria infection by on activities and accomplishments Institute of Allergy and Infectious blocking nutrients to plasmodium related to the Open Water Data Diseases, 5601 Fishers Lane, Suite 6D, parasites. Initiative, and a report on the MSC9804, Rockville, MD 20852–9804 This notice is made in accordance Hydrologic Frequency Analysis Work Telephone: (301) 496–2644; Facsimile: with 35 U.S.C. 209 and 37 CFR part 404. Group’s progress on Bulletin 17C, (240) 627–3117; Email: peter.tung@ The prospective exclusive license will Guidelines For Determining Flood Flow nih.gov. be royalty bearing, and the prospective Frequency. SUPPLEMENTARY INFORMATION: exclusive license may be granted unless The ACWI was established under the within fifteen (15) days from the date of authority of the Office of Management Intellectual Property this published notice, the National and Budget Memorandum M–92–01 and United States Provisional Patent Institute of Allergy and Infectious the Federal Advisory Committee Act. Application No. 61/083,000, filed July Diseases receives written evidence and The purpose of the ACWI is to provide 23, 2008 and entitled ‘‘Inhibitors of the argument that establishes that the grant a forum for water information users and Plasmodial Surface Anion Channel as professionals to advise the Federal sradovich on DSK3GMQ082PROD with NOTICES of the license would not be consistent Antimalarials’’ [HHS Reference No. E– with the requirements of 35 U.S.C. 209 Government on activities and plans that 202–2008/0–US–01]; PCT Patent and 37 CFR part 404. may improve the effectiveness of Application PCT/US09/50637, filed July Complete applications for a license in meeting the Nation’s water information 15, 2009 and entitled ‘‘Inhibitors of the the prospective field of use that are filed needs. Member organizations help to Plasmodial Surface Anion Channel as in response to this notice will be treated foster communications between the Antimalarials’’ [HHS Reference No. E– as objections to the grant of the Federal and non-Federal sectors on 202–2008/0–PCT–02]; and U.S. and contemplated Exclusive sharing water information. VerDate Sep<11>2014 18:11 Feb 08, 2017 Jkt 241001 PO 00000 Frm 00043 Fmt 4703 Sfmt 4703 E:\FR\FM\09FEN1.SGM 09FEN1


Document Created: 2017-02-09 01:02:55
Document Modified: 2017-02-09 01:02:55
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
DatesMarch 6, 2017.
FR Citation82 FR 10024 
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR